Previous administration of indomethacin or naloxone did not influence ketorolac antinociception in mice
Author
dc.contributor.author
Miranda, Daniela
Author
dc.contributor.author
Sierralta, Fernando
Author
dc.contributor.author
Pinardi,
Admission date
dc.date.accessioned
2019-01-29T14:52:53Z
Available date
dc.date.available
2019-01-29T14:52:53Z
Publication date
dc.date.issued
1993
Cita de ítem
dc.identifier.citation
Anesthesia and Analgesia, Volumen 77, Issue 4, 2018, Pages 750-753
Identifier
dc.identifier.issn
00032999
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/161120
Abstract
dc.description.abstract
We studied the effects of the inhibition of prostaglandin biosynthesis and opioid antagonism in the antinociceptive action of ketorolac using the mouse acetic acid writhing test. Ketorolac was administered via the intraperitoneal, intrathecal, or intracerebroventricular routes. Although the ketorolac induced a significant dose-dependent antinociceptive effect, the intracerebroventricular administration was the most effective route. Indomethacin and naloxone pretreatments did not change the ketorolac-induced antinociception. The present findings suggest that this antinociceptive action of ketorolac is not mediated by the inhibition of prostaglandin biosynthesis nor by activation of opioid receptors.